摘要
餐后高血糖是最早反应血糖控制异常的指标之一,餐后高血糖使糖耐量异常向2型糖尿病方向发展,同时也是糖耐量减低和2型糖尿病患者并发症发生的危险因素[1]。因此,在糖代谢受损患者中,对于防治向糖尿病方向发展,降低餐后高血糖尤为重要。阿卡波糖是一种α-糖苷酶抑制剂,可通过延缓碳水化合物在小肠中的吸收,降低餐后高血糖,这一作用机制可以在不升高胰岛素水平的情况下控制血糖[2]。
According to GPP standards, the construction in software and hardware of our hospital should be improved and the management of hospital preparation should be regulated. As long as hospital preparation can be closely combined with clinic, product structure adjusted relying on scientific research and Chinese characteristic medicine developed, it will be enhanced in quality and therefore develop sustainably.
出处
《中国医学创新》
CAS
2012年第12期159-160,共2页
Medical Innovation of China
关键词
阿卡波糖
2型糖尿病
糖耐量
脂代谢
Hospital preparation
Chinese material preparation
Construction
Development
